Prognostic impact of preoperative echocardiography in elderly patients with fragility hip Fracture: A Randomized Controlled Trial

Not Applicable

Conditions: Diseases of the musculoskeletal system and connective tissue

Registration Number: KCT0007636

Lead Sponsor: The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot yet recruiting

Sex: All

Target Recruitment: 160

Inclusion Criteria

(1) For adults over the age of 65 who undergo surgical treatment for fragility hip fractures.
(2) ASA grade 3 or higher (1-3)
(3) Koval activity grade 5 or higher (1-5)
(4) Patients who are able to comply with and cooperate with outpatient follow-up, functional and radiological evaluation after surgery
(5) A patient who understands the study and has given written consent by the patient's own or the patient's representative to participate in the study.

Exclusion Criteria

(1) Patients who have difficulty breathing, chest pain, fainting or significant dizziness or who have worsened within the last 3 months
(2) ASA grade 4 and below (4-6)
(3) Patients with a revised cardiac risk index of 3 or higher
(4) Patients who were unable to walk independently prior to the fracture: Koval activity grade 6 or less (6-7)
(5) Among ASA grade 3 patients, if you have cardiovascular disease (heart failure, heart valve disease, coronary artery disease, coronary artery interventional strength, artificial pacemaker/intra-heart device retention, dialysis patients, serious arrhythmias such as atrial fibrillation, chronic obstructive pulmonary disease, etc.) and the evaluation of heart function has not been carried out within the last 1 year.
(6) If there was a previous local infection, sepsis, lower extremity vein thrombosis, etc. in the lower extremities at the surgical site
(7) Patients with past surgical history in the hip joint
(8) Patients who are not able to be tracked after alcohol and on an outpatient basis

Study & Design

Study Type: Interventional Study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Troponin-I, CK-MB, NT pro BNP level ;Hip x-ray;VAS Pain Score;Harris Hip Score ;Western Ontario and McMaster Universities Index (WOMAC index) ;EQ-5D index (Quality of life)

Secondary Outcome Measures